BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
1-Year Return
97.06%
This Quarter Return
+29.54%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$61.1M
AUM Growth
+$5.88M
(+11%)
Cap. Flow
-$9.1M
Cap. Flow
% of AUM
-14.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$9.1M |
Sector Composition
| 1 | Healthcare | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $55.7M | 91.25% |
1,864,174
-304,427
| -14% | -$9.1M |
|
2
ADMA Biologics
ADMA
$3.92B
| $5.3M | 8.68% |
1,433,304
| – | – |
|
|
MBVX
3
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $37K | 0.06% |
8,903
| – | – |
|